Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review.

ABSTRACT: Hepatitis C virus (HCV) infects 180 million people worldwide and over 4 million people in the United States. HCV infection is a major cause of chronic liver disease and is recognized as a risk factor for clinical cardiovascular disease (CVD). Many studies have shown increased prevalence of cardiac and inflammatory biomarkers in patients with chronic HCV infection (CHC), and though these markers may be used to risk stratify people for cardiac disease in the general population their role in the HCV population is unknown. Patients with CHC have elevated cardiac and inflammatory biomarkers compared to noninfected controls which may play a role in CVD risk stratification. We undertook a systematic review of inflammatory and cardiac biomarkers in people with HCV infection with a focus on the eff

SUBMITTER: Babiker A 

PROVIDER: S-EPMC7068107 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature